Currently, Amgen Inc (NASDAQ:AMGN) has a Hold using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 3 months.

Amgen Inc (NASDAQ:AMGN) ranks in the top 10% of its industry group, Biotechnology, and in the top decile of sector group, Health Care, with a market value of $128.8 billion. From an investment attractiveness viewpoint, AMGN is ranked in the top half of the sector with a ranking of 344 among the 782 companies in the sector; Portfolio Grader's current ranking for AMGN puts it 143 among the 350 companies in this industry group, placing it in the top half and number 2,021 in the 5000 company Portfolio Grader company universe.

The current recommendation of Hold for Amgen Inc (NASDAQ:AMGN) has been derived by using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. AMGN has maintained this ranking for 2 months.

Amgen Inc (NASDAQ:AMGN) is ranked as a Hold using Louis Navellier's investing system and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking AMGN has had from Portfolio Grader for 2 months.

Amgen Inc (NASDAQ:AMGN) is ranked as a Hold using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing system. This represents no change from the previous week and is the same ranking AMGN has had from Portfolio Grader for 2 months.

As one of the 785 companies in the GICS Health Care sector Amgen Inc (NASDAQ:AMGN) is a component of the 349 company Biotechnology GICS industry group within this sector. AMGN's market value is $126.0 billion which falls in the top decile in its industry group. Portfolio Grader's current ranking for AMGN puts it 133 among the 349 companies in this industry group, putting it in the second quartile; in the top half of the sector with a ranking of 320 among the 785 companies in the sector, and number 2,050 in the nearly 5,000 company Portfolio Grader universe.

Currently, Amgen Inc (NASDAQ:AMGN) has a Hold using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking AMGN has had from Portfolio Grader for the last month.

Portfolio Grader currently ranks Amgen Inc (NASDAQ:AMGN) a Hold. The methodology for investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking AMGN has had from Portfolio Grader for the last month.

Currently, Amgen Inc (NASDAQ:AMGN) has a Hold using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Currently, Amgen Inc (NASDAQ:AMGN) has a Hold using the methods of Louis Navellier for investing and his Portfolio Grader stock evaluator. The shares have been upgraded from a Sell to a Hold in the last week.